Vitamin C could help defeat blood-brain barrier

Drugs which are unable to pass the blood-brain barrier, which stops
them getting into the brain where they could be potentially
beneficial to health, could hitch a ride on the back of vitamin C,
according to new research from Italy.

Drugs which are unable to pass the blood-brain barrier, which stops them getting into the brain where they could be potentially beneficial to health, could hitch a ride on the back of vitamin C, according to new research from Italy.

A team led by Dr. Stefano Manfredini from the University of Ferrara found that drugs used to treat neurological disorders such as Alzheimer's or epilepsy can get past the blood-brain barrier more easily when helped by a vitamin C molecule.

The researchers focused on the ascorbic acid SVCT2 transporter, which is believed to play a major role in regulating the transport of vitamin C into the brain. They assessed the effect of adding vitamin C to drugs which find it hard to cross the blood-brain barrier - namely diclophenamic acid, nipecotic acid and kynurenic acid - and found that the additional component made it much easier for them to interact with the transporter.

Glucose and amino acids have already shown an ability to cross the blood-brain barrier, but they do not guarantee a selective target. The benefits of using SVCT2 is that it can deliver the drug directly to the central nervous system, Manfredini said.

Related topics Research Suppliers

Follow us

Products

View more

Webinars